DE OTC Drug Marketing - State Board of Pharmacy
OTC drug marketing to Delaware consumers must keep claims within label or monograph uses, avoid absolute or unsupported comparative claims, and carry a Drug Facts panel on labels; ads need not repeat Drug Facts.
6 Del. C. § 2513(a); 15 U.S.C. § 52(a); 21 U.S.C. § 352(a); 21 C.F.R. § 201.66(c)